Dechra Pharmaceuticals PLC:企業のM&A・事業提携・投資動向

◆英語タイトル:Dechra Pharmaceuticals PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2059
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:63
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Dechra Pharmaceuticals PLC – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Dechra Pharmaceuticals PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Dechra Pharmaceuticals PLC since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Dechra Pharmaceuticals PLC’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Dechra Pharmaceuticals PLC. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Dechra Pharmaceuticals PLC’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Dechra Pharmaceuticals PLC and its subsidiaries since 2007.
- Information about key financial and legal advisors for Dechra Pharmaceuticals PLC’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Dechra Pharmaceuticals PLC’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
PARTNERSHIP 33
Partnership – Deal reports 33
CAPITAL RAISING 46
Capital Raising – Overview 46
Capital Raising – Deal reports 47
Divestments – Deal reports 50
APPENDIX 53
Contact Us 53
About MarketLine Financial Deals Database 53
Deal Definition and Methodology 55
About MarketLine 62

List of Tables
Table 1: Dechra Pharmaceuticals PLC M&A volume and value trend (2014-YTD2018)
Table 2: Dechra Pharmaceuticals PLC M&A activity by geography (2014-YTD2018)
Table 3: Dechra Pharmaceuticals PLC capital raising volume and value trend (2014-YTD2018)
Table 4: Dechra Pharmaceuticals PLC capital raising by deal type (2014-YTD2018)

List of Figures
Figure 1: Dechra Pharmaceuticals PLC M&A volume and value trend (2014-YTD2018)
Figure 2: Dechra Pharmaceuticals PLC M&A activity by geography (2014-YTD2018)
Figure 3: Dechra Pharmaceuticals PLC capital raising volume and value trend (2014-YTD2018)
Figure 4: Dechra Pharmaceuticals PLC capital raising by deal type (2014-YTD2018)

★海外企業調査レポート[Dechra Pharmaceuticals PLC:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Enmax Corporation:企業の戦略的SWOT分析
    Enmax Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Falck Renewables S.p.A. (FKR)-エネルギー分野:企業M&A・提携分析
    Summary Falck Renewables S.p.A. (Falck Renewables), formerly Actelios S.p.A., develops, designs, constructs and manages energy production plants. It operates as a subsidiary of Falck S.p.A. The company produces clean energy from various renewable sources including wind energy, solar energy, biomass …
  • Bausch Health Companies Inc (BHC):企業の財務・戦略的SWOT分析
    Bausch Health Companies Inc (BHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Commercial Bank International PSC:企業の戦略・SWOT・財務情報
    Commercial Bank International PSC - Strategy, SWOT and Corporate Finance Report Summary Commercial Bank International PSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Valneva SE:企業のM&A・事業提携・投資動向
    Valneva SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Valneva SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • DEA Deutsche Erdoel AG:石油・ガス:M&Aディール及び事業提携情報
    Summary DEA Deutsche Erdoel AG (DEA), a subsidiary of Letterone Holdings S.A., is an upstream company that explores for and produces oil and natural gas. The company operates onshore and offshore projects in Egyptian Nile delta, Mittelplate Island and Norwegian coast line and other regions. It also …
  • SeraCare Life Sciences, Inc.:医療機器:M&Aディール及び事業提携情報
    Summary SeraCare Life Sciences, Inc. (SeraCare) carries out the discovery, development, manufacture and supply of disease-state specimens and tissues for research and development, processed biological materials, immunoassay reagents and quality control products and technologies. Its major products i …
  • Brunel International NV (BRNL):企業の財務・戦略的SWOT分析
    Brunel International NV (BRNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • The Aerospace Corp:企業の戦略的SWOT分析
    The Aerospace Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • U.S. Department of Veterans Affairs-製薬・医療分野:企業M&A・提携分析
    Summary U.S. Department of Veterans Affairs (DVA) is a healthcare organization that provides benefit management and veteran services. The organization provides general benefits information, disability compensation, pension, GI bill, vocational rehabilitation and employment, vet success, educational …
  • BB Biotech AG (BION):企業の財務・戦略的SWOT分析
    Summary BB Biotech AG (BB Biotech) is a financial service provider that offers biotechnology investments. The company invests in markets that develop new drugs and therapies for use in the treatment of autoimmune and infectious diseases, oncology disorders, cardiovascular diseases, and metabolic dis …
  • Escher Group Holdings plc:企業の戦略・SWOT・財務情報
    Escher Group Holdings plc - Strategy, SWOT and Corporate Finance Report Summary Escher Group Holdings plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Slanchev den AD Varna:企業の戦略・SWOT・財務情報
    Slanchev den AD Varna - Strategy, SWOT and Corporate Finance Report Summary Slanchev den AD Varna - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Business Connexion Group Limited:企業の戦略的SWOT分析
    Business Connexion Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Axela Inc:製品パイプライン分析
    Summary Axela Inc (Axela), formerly Axela Biosensors Inc is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers technical and …
  • Sapporo Holdings Ltd (2501):企業の財務・戦略的SWOT分析
    Sapporo Holdings Ltd (2501) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Proteomics International Laboratories Ltd (PIQ):製品パイプライン分析
    Summary Proteomics International Laboratories Ltd (Proteomics International), a wholly-owned subsidiary and trading name of PILL, is a medical technology company, which focuses on proteomics, the study of structure and function of proteins. The company harnesses its proprietary proteomics-based tech …
  • Innoviva Inc (INVA):企業の財務・戦略的SWOT分析
    Innoviva Inc (INVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • C.H. Robinson Worldwide Inc (CHRW):企業の財務・戦略的SWOT分析
    C.H. Robinson Worldwide Inc (CHRW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Bayer CropScience AG:企業のM&A・事業提携・投資動向
    Bayer CropScience AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bayer CropScience AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆